Can this trend continue?
The charts of the footwear and apparel giant are not sending bullish signals in advance of its third-quarter results next week.
Let's check the charts and indicators.
The message from the chart is clear.
The tech giant's stock won a buy rating from Goldman Sachs, and its work on a medical innovation could be a game-changer.
JP Morgan raises the consumer products giant to an overweight rating, but its shares still aren't displaying much technical vigor.
The crypto-based bank has delayed their annual SEC filing. Let's check the charts.
Trying to catch this drug developer's stock appears risky.
The chipmaker's shares have traded sideways the past year in what looks like an inverse head-and-shoulders bottom pattern
It looks like ZM is still working on its 'phoenix' rally....